- Home
- MIST vs KTOS Comparison
MIST vs KTOS Comparison
Compare MIST & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- KTOS
- Stock Information
- Founded
- MIST 2003
- KTOS 1994
- Country
- MIST Canada
- KTOS United States
- Employees
- MIST N/A
- KTOS N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- KTOS Military/Government/Technical
- Sector
- MIST Health Care
- KTOS Industrials
- Exchange
- MIST Nasdaq
- KTOS Nasdaq
- Market Cap
- MIST 145.3M
- KTOS 10.0B
- IPO Year
- MIST N/A
- KTOS 1999
- Fundamental
- Price
- MIST $1.94
- KTOS $75.74
- Analyst Decision
- MIST Strong Buy
- KTOS Strong Buy
- Analyst Count
- MIST 3
- KTOS 14
- Target Price
- MIST $6.33
- KTOS $56.79
- AVG Volume (30 Days)
- MIST 1.2M
- KTOS 2.9M
- Earning Date
- MIST 11-11-2025
- KTOS 11-06-2025
- Dividend Yield
- MIST N/A
- KTOS N/A
- EPS Growth
- MIST N/A
- KTOS 31.73
- EPS
- MIST N/A
- KTOS 0.09
- Revenue
- MIST N/A
- KTOS $1,213,100,000.00
- Revenue This Year
- MIST N/A
- KTOS $17.66
- Revenue Next Year
- MIST N/A
- KTOS $18.10
- P/E Ratio
- MIST N/A
- KTOS $801.87
- Revenue Growth
- MIST N/A
- KTOS 7.76
- 52 Week Low
- MIST $0.63
- KTOS $22.17
- 52 Week High
- MIST $2.75
- KTOS $76.72
- Technical
- Relative Strength Index (RSI)
- MIST 64.09
- KTOS 73.92
- Support Level
- MIST $1.75
- KTOS $61.40
- Resistance Level
- MIST $2.06
- KTOS $65.29
- Average True Range (ATR)
- MIST 0.09
- KTOS 3.19
- MACD
- MIST 0.02
- KTOS 0.70
- Stochastic Oscillator
- MIST 66.67
- KTOS 91.76
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.